Invention Grant
- Patent Title: HU specific interfering agents
-
Application No.: US15952129Application Date: 2018-04-12
-
Publication No.: US11690892B2Publication Date: 2023-07-04
- Inventor: Lauren O. Bakaletz , Steven D. Goodman
- Applicant: Research Institute at Nationwide Children's Hospital
- Applicant Address: US OH Columbus
- Assignee: Research Institute at Nationwide Children's Hospital
- Current Assignee: Research Institute at Nationwide Children's Hospital
- Current Assignee Address: US OH Columbus
- Agency: Foley & Lardner LLP
- Main IPC: A61K39/02
- IPC: A61K39/02 ; A61K39/09 ; A61K38/16 ; A61K9/16 ; A61K35/744 ; A61K47/69 ; C07K14/315 ; C07K16/12 ; A61K47/36

Abstract:
Methods of and compositions for breaking down a biofilm or inhibiting, preventing or treating a microbial infection that produces a biofilm are disclosed, which involves administration of an interfering agent capable of specifically competing, titrating, or inhibiting the binding of an HU protein to a microbial DNA. By competing with HU proteins that bind to DNA scaffold in the biofilm, these interfering agents destabilize the biofilm leading to destruction and removal of the biofilm by the immune system. Further method and composition aspects are contemplated in relation to infections caused by bacteria that export an HU protein.
Public/Granted literature
- US20180303900A1 HU SPECIFIC INTERFERING AGENTS Public/Granted day:2018-10-25
Information query